← All companies
K
Kiniksa Pharmaceuticals, Ltd.
KNSA - Company ID 0001730430
Market cap$3.75 B
Rank#1658
Filings733
Kiniksa Pharmaceuticals, Ltd. has filed 733 public company documents between 2018 and 2026. The most frequent type is insider trade (335 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Continue researchKNSA overview$3.75 BMarket cap, financials, charts, and latest company context.
Continue researchMarket cap historyRank #1658See the market value trend behind the filing history.
Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.
Continue researchCompare with LLYPeer viewPut KNSA beside LLY across market cap, revenue, income, and filings.
Similar companies to research next
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.